Efficacy of DYRK1A inhibitors in novel models of Down syndrome acute lymphoblastic leukemia.
Carey-Smith SL, Simad MH, Panchal K, Aya-Bonilla C, Smolders H, Lin S, Armitage JD, Nguyen VT, Bentley K, Ford J, Singh S, Oommen J, Laurent AP, Mercher T, Crispino JD, Montgomery AP, Kassiou M, Besson T, Deau E, Meijer L, Cheung LC, Kotecha RS, Malinge S.
Carey-Smith SL, et al. Among authors: singh s.
Haematologica. 2024 Feb 29. doi: 10.3324/haematol.2023.284271. Online ahead of print.
Haematologica. 2024.
PMID: 38426275
Free article.